Increased Odds of Metabolic Dysfunction-Associated Steatotic Liver Disease Are Linked to Reduced n-6, but Not n-3 Polyunsaturated Fatty Acids in Plasma
Biomolecules · 2024
DOI: 10.3390/biom14080902 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2024. Verfasst von Irena Frankovic und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biochemistry, Faculty of Pharmacy, University of Belgrade, 11000 Belgrade, Serbia. Hauptthemen laut MEDLINE: Fatty Acids, Omega-6, Fatty Acids, Omega-3. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science, Technological Development and Innovation, Republic of Serbia.
Abstract (Originalsprache)
The increasing prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) underscores the need for better understanding of its complex pathogenesis. Lipid accumulation in hepatocytes is among principal mechanisms contributing to MASLD development. While routine lipid parameters are well studied, the profile of circulating fatty acids in MASLD patients remains less explored. This study aimed to assess relative proportions of individual fatty acids in plasma of MASLD patients and to explore their associations with other biochemical markers of MASLD. Ninety-one patients and 48 healthy individuals were enrolled. The relative proportions of fatty acids in plasma were determined using gas chromatography with FID detection. Proportions of total n-6 polyunsaturated fatty acids (PUFAs) and linoleic acid (LA) in plasma were lower in MASLD patients (p = 0.001 and p = 0.004, respectively), with no differences observed in n-3 PUFAs. Total plasma n-6 PUFAs correlated negatively with body mass index, hepatic steatosis indices, triglyceride concentration and coronary risk index. Decreased prevalence of n-6 PUFAs in plasma was independently associated with higher odds of MASLD (OR = 0.769; CI: 0.611–0.968; p = 0.025). Our findings indicate an altered circulatory fatty acid distribution in MASLD, characterized by a reduced amount of n-6 PUFAs, particularly LA, which may have significant implications for the prevention and treatment of MASLD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Biochemistry, Faculty of Pharmacy, University of Belgrade, 11000 Belgrade, Serbia.
- Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
- Department of Gastroenterology and Hepatology, Clinic for Internal Medicine, Clinical Hospital Center Zemun, 11080 Belgrade, Serbia.
- Department of Laboratory Diagnostics, Clinical Hospital Center Zemun, 11080 Belgrade, Serbia.
- Clinical Department for Gastroenterology and Hepatology, University Medical Center Zvezdara, 11000 Belgrade, Serbia.
ORCID-Profile: Ivana Djuricic, Ana Ninic, Sanja Erceg, Milos Mitrovic, Aleksandra Zeljkovic
Förderung
- Ministry of Science, Technological Development and Innovation, Republic of Serbia
Zitieren
APA
Frankovic, I., Djuricic, I., Ninic, A., Vekic, J., Vorkapic, T., Erceg, S., Gojkovic, T., Tomasevic, R., Mamic, M., Mitrovic, M., & Zeljkovic, A. (2024). Increased Odds of Metabolic Dysfunction-Associated Steatotic Liver Disease Are Linked to Reduced n-6, but Not n-3 Polyunsaturated Fatty Acids in Plasma. Biomolecules. https://doi.org/10.3390/biom14080902
Vancouver
Frankovic I, Djuricic I, Ninic A, Vekic J, Vorkapic T, Erceg S, et al. Increased Odds of Metabolic Dysfunction-Associated Steatotic Liver Disease Are Linked to Reduced n-6, but Not n-3 Polyunsaturated Fatty Acids in Plasma. Biomolecules. 2024. doi:10.3390/biom14080902
BibTeX
@article{Frankovic2024,
author = {Frankovic, Irena and Djuricic, Ivana and Ninic, Ana and Vekic, Jelena and Vorkapic, Tara and Erceg, Sanja and Gojkovic, Tamara and Tomasevic, Ratko and Mamic, Milica and Mitrovic, Milos and Zeljkovic, Aleksandra},
title = {Increased Odds of Metabolic Dysfunction-Associated Steatotic Liver Disease Are Linked to Reduced n-6, but Not n-3 Polyunsaturated Fatty Acids in Plasma},
journal = {Biomolecules},
year = {2024},
doi = {10.3390/biom14080902}
}
EUVIMED